HAL (France)
open access
De Novo Serine Synthesis Is a Metabolic Vulnerability That Can Be Exploited to Overcome Sunitinib Resistance in Advanced Renal Cell Carcinoma
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- In Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia)#915330
- Metabolic Remodeling in Glioblastoma: A Longitudinal Multi-Omics Study#1066402
- Spatially-guided metabolomics profiling of metabolic regions in human tumor tissues.#340447
- Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma#279491
- CPG 7909 in Patients Wih Stage IV Renal Cell Cancer#140981
Record · ID 257504
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive